Visualitza per autor "Melisi, Davide"
Ara mostrant els elements 1-4 d 4
-
First-line and second-line treatment of patients with metastatic pancreatic adenocarcinoma in routine clinical practice across Europe: a retrospective, observational chart review study
Prager, Gerald W; Westphalen, C Benedikt; D'Esquermes, Nathalie; Ferreras, Anabel; Macarulla Mercadé, Teresa; Taieb, Julien; Melisi, Davide (BMJ, 2020-01-20) -
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Wainberg, Zev; Melisi, Davide; Pazo-Cid, Roberto A.; Chandana, Sreenivasa R; DE LA FOUCHARDIERE, CHRISTELLE; Macarulla, Teresa (Elsevier, 2023-10-07) -
Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
Hollebecque, Antoine; Varghese, Anna; Borazanci, Erkut; Macarulla Mercadé, Teresa; Oh, Do-Youn; Melisi, Davide; Calvo, Emiliano (BMJ Publishing Group, 2021-03-09) -
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study
Patel, Nikunj; Lie, Xandra; Gwaltney, Chad; Rokutanda, Nana; Barzi, Afsaneh; Macarulla Mercadé, Teresa; Melisi, Davide (Springer, 2021-12)